Macter International Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, MACTER's sales rose 8% to Rs 2.9bn, from Rs 2.7bn, and profit after tax fell 51% to Rs 145.9mn, from Rs 298.8mn (compared with Apr–Jun 2025).
Earnings per share were Rs 3.33, against Rs 6.31 a year earlier.
At Rs 247.50, MACTER trades at 15.3 times earnings.
- P/E ratio
- 15.3
- Dividend yield
- 0.0%
- Dividend payout
- 0%
- of earnings
- Return on equity
- 16%
- Net margin
- 6.0%
- trailing twelve months
- Debt to equity
- 0.29
MACTER quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 2.9bn | Rs 145.9mn | 5.0% | Rs 3.33 | — |
| Jan–Mar 2026 | Rs 2.9bn | Rs 92.5mn | 3.2% | Rs 2.01 | — |
| Oct–Dec 2025 | Rs 3.5bn | Rs 291.5mn | 8.3% | Rs 6.27 | — |
| Jul–Sep 2025 | Rs 2.9bn | Rs 145.3mn | 5.1% | Rs 3.22 | — |
| Apr–Jun 2025 | Rs 2.7bn | Rs 298.8mn | 11.1% | Rs 6.31 | Rs 2.00 |
| Jan–Mar 2025 | Rs 2.5bn | Rs 91.2mn | 3.6% | Rs 2.00 | Rs 1.80 |
| Oct–Dec 2024 | Rs 2.9bn | Rs 308.5mn | 10.7% | Rs 6.69 | — |
| Jul–Sep 2024 | Rs 2.3bn | Rs 88.4mn | 3.9% | Rs 1.95 | — |
MACTER annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Jun 2026 | Rs 12.2bn | Rs 675.2mn | Rs 14.83 | — |
| Year to Jun 2025 | Rs 10.4bn | Rs 786.9mn | Rs 16.95 | Rs 3.80 |
| Year to Jun 2024 | Rs 8.0bn | Rs 402.2mn | Rs 8.88 | Rs 2.25 |
| Year to Jun 2023 | Rs 6.7bn | Rs 393.0mn | Rs 8.58 | Rs 1.08 |
| Year to Jun 2022 | Rs 5.3bn | Rs 318.0mn | Rs 7.18 | Rs 3.21 |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 7.9bn
- Shareholders' equity
- Rs 4.2bn
- Cash & bank
- Rs 109.8mn
- Total debt
- Rs 1.2bn
- Current ratio
- 1.79
- 3-month high
- Rs 308.58
- 3-month low
- Rs 238.05
- 1-month change
- -7.2%
- 3-month change
- -19.8%
Read more about MACTER
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- AGPAGP LtdRs 157.87P/E 12.7
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- LIVENLiven Pharma LimitedRs 31.14
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
MACTER: common questions
What is MACTER's share price?
Macter International Ltd (MACTER) last closed at Rs 247.50 on the Pakistan Stock Exchange.
Does MACTER pay a dividend?
Macter International Ltd reported no dividend for the year to Jun 2026.
What were MACTER's latest results?
In the Apr–Jun 2026 quarter, MACTER's sales rose 8% to Rs 2.9bn, from Rs 2.7bn, and profit after tax fell 51% to Rs 145.9mn, from Rs 298.8mn (compared with Apr–Jun 2025).
What is MACTER's P/E ratio?
At Rs 247.50, MACTER trades at 15.3 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.